DBV TECHNOLOGIES |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.186 EUR | -1.17% |
|
-4.35% | -35.86% |
Chart calendar DBV Technologies
a7a42ad501ec635ffb49e690.dwsWIxjZ4eBvtlCgkpCjMbkGz1iLrPr1HY_Qv7AKiZo.Om1Fc0KsjYNZ7zmWwaXgQI5iqm_x4JHCf9vp0tdY48MdTl9VUI-QtQPgGQ~87b26d5b6a033bc57037a395190e3978
Upcoming events on DBV Technologies
Past events on DBV Technologies
| 07/03/2024 22:00 | Q4 2023 Earnings Call |
| 07/03/2024 21:30 | Q4 2023 Earnings Release |
| 24/02/2024 19:15 | American Academy of Allergy Asthma and Immunology Meeting |
| 24/02/2024 14:45 | American Academy of Allergy Asthma and Immunology Meeting - Poster No: 379 |
| 12/11/2023 01:45 | American College of Allergy Asthma Immunology Scientific Meeting |
| 11/11/2023 17:40 | American College of Allergy Asthma & Immunology Scientific Meeting - Abstract ID: LB010 |
| 11/11/2023 17:35 | American College of Allergy Asthma & Immunology Scientific Meeting |
| 09/11/2023 22:00 | American College of Allergy Asthma & Immunology Scientific Meeting |
| 31/10/2023 21:00 | Q3 2023 Earnings Call |
| 31/10/2023 20:30 | Q3 2023 Earnings Release |
| 12/09/2023 21:00 | H.C. Wainwright Global Investment Conference |
| 31/07/2023 22:00 | Q2 2023 Earnings Call |
| 31/07/2023 21:25 | Q2 2023 Earnings Release |
| 14/06/2023 18:00 | Goldman Sachs Global Healthcare Conference |
| 11/06/2023 11:45 | European Academy of Allergy and Clinical Immunology Congress - Session title: Asthma 3 |
| 11/06/2023 11:45 | European Academy of Allergy and Clinical Immunology Congress - Efficacy and Safety of Epicutaneous I |
| 10/06/2023 11:00 | European Academy of Allergy and Clinical Immunology Congress |
| 10/06/2023 11:00 | European Academy of Allergy and Clinical Immunology Congress - Food allergy 2 |
| 09/06/2023 11:00 | European Academy of Allergy and Clinical Immunology Congress - Food allergy 1 |
| 15/05/2023 14:00 | JMP Securities Life Sciences Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 13,1 14,7 -10.6% | 9,42 14,8 -36.11% | 5,17 4,32 19.52% | 4,53 7,04 -35.67% | 14,4 7,78 85.06% | 6,53 |
|
EBITDA Million EUR | Released Forecast Spread | -149 -155 3.98% | -104 -140 25.29% | -82,3 -87,9 6.4% | -78,7 -67,4 -16.85% | -82,7 -83,0 0.35% | -131 |
|
EBIT Million EUR | Released Forecast Spread | -152 -161 5.55% | -113 -150 24.82% | -89,8 -87,2 -2.88% | -90,7 -77,6 -16.98% | -69,9 -87,3 19.9% | -117 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -153 -193 20.58% | -133 -163 18.27% | -144 -97,5 -48.12% | -90,4 -76,2 -18.68% | -66,5 -85,0 21.7% | -114 |
|
Net income Million EUR | Released Forecast Spread | -154 -175 12.18% | -133 -166 19.63% | -144 -96,9 -49.04% | -90,5 -75,0 -20.7% | -66,5 -81,6 18.44% | -107 |
|
EPS EUR | Released Forecast Spread | -4,15 -3,89 -6.68% | -2,47 -3,88 36.41% | -1,62 -1,75 7.46% | -1,17 -0,87 -34.02% | -0,70 -0,88 20.8% | -0,77 |
| Announcement Date | 04/03/20 | 11/03/21 | 03/03/22 | 02/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 6,04 7,44 -18.82% | 7,60 6,72 13.17% | 4,07 7,00 -41.9% | 2,65 1,17 126.96% | 2,42 1,18 106.06% | 1,49 1,15 28.92% | 2,13 1,15 84.38% | -1,27 1,01 -225.48% | 2,00 1,05 89.69% | 2,09 0,79 165.69% | 2,27 1,27 79.37% | 8,12 1,11 629.94% | 1,63 | 1,63 | 1,63 | 1,63 |
|
EBIT Million EUR | Released Forecast Spread | -72,4 -83,6 13.38% | -66,6 -77,1 13.6% | -44,7 -81,9 45.41% | -12,7 -28,7 55.69% | -16,0 -23,9 33.28% | -23,2 -16,9 -37% | -18,5 -26,0 29.1% | -35,4 -19,3 -83.92% | -19,2 -23,8 19.59% | -22,7 -24,2 6.23% | -17,2 -26,0 33.82% | -10,9 -30,5 64.18% | -26,0 | -28,2 | -30,5 | -32,0 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -73,2 -83,6 12.34% | -86,5 -78,1 -10.76% | -45,0 -82,3 45.34% | -68,3 -32,3 -111.89% | -15,8 -23,9 33.89% | -22,4 -17,6 -27.34% | -17,7 -29,3 39.47% | -36,7 -21,6 -70.04% | -18,6 -22,4 16.96% | -22,0 -21,9 -0.36% | -15,8 -25,5 37.91% | -10,2 -30,2 66.05% | -19,0 | -22,3 | -26,3 | -31,2 |
|
Net income Million EUR | Released Forecast Spread | -73,8 -83,6 11.68% | -86,5 -77,2 -12.03% | -45,0 -82,3 45.35% | -68,3 -27,8 -146.18% | -15,9 -23,9 33.54% | -22,4 -17,5 -27.8% | -17,7 -27,5 35.63% | -36,7 -19,7 -86.32% | -18,6 -21,1 11.83% | -22,0 -21,4 -2.82% | -15,8 -24,6 35.67% | -10,2 -23,8 57.02% | -19,7 | -23,0 | -26,6 | -30,7 |
|
EPS EUR | Released Forecast Spread | -0,23 -0,45 47.73% | -0,29 -0,40 29.32% | -0,34 -0,27 -28.08% | -0,18 -0,24 24.41% | -0,42 -0,18 -137.07% | -0,20 -0,27 26.49% | -0,24 -0,28 16.04% | -0,16 -0,27 40.84% | -0,10 -0,31 67% | -0,33 | -0,21 | -0,16 | -0,14 | |||
| Announcement Date | 04/03/20 | 31/07/20 | 11/03/21 | 03/03/22 | 02/05/22 | 01/08/22 | 03/11/22 | 02/03/23 | 04/05/23 | 31/07/23 | 31/10/23 | 07/03/24 | - | - | - | - |
More events
Past sector events for DBV Technologies
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DBV Stock
- Calendar DBV Technologies
